WCA
HCAT icon

Whetstone Capital Advisors’s Health Catalyst HCAT Stock Holding History

Whetstone Capital Advisors’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.92M Buy
+1,515,000
New +$2.85M 0.67% 24

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $157M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PVM
Palogic Value Management Dallas, Texas $237M AUM 5.37% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Whetstone Capital Advisors's HCAT Position: Q1 2026 in Review

Whetstone Capital Advisors increased its Health Catalyst (HCAT) stake by 14% in Q1 2026, buying an estimated $974K and bringing the position to 4,268,141 shares worth $5.42M. The position accounts for 1.88% of the portfolio, ranked #14.

Whetstone Capital Advisors first reported a position in HCAT in Q1 2025 and has held it in 5 quarters since. The position peaked at $14.1M in Q2 2025. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

  • Whetstone Capital Advisors held 4,268,141 shares of Health Catalyst worth $5.42M as of Q1 2026.
  • Whetstone Capital Advisors bought 517,764 Health Catalyst shares in Q1 2026, an estimated $974K.
  • Health Catalyst made up 1.88% of Whetstone Capital Advisors's portfolio in Q1 2026, its #14 holding.
  • Whetstone Capital Advisors first reported a position in Health Catalyst in Q1 2025 and has held it in 5 quarters since.
  • Whetstone Capital Advisors's Health Catalyst position peaked at $14.1M in Q2 2025.
  • 130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on Whetstone Capital Advisors's 13F filing for Q1 2026, filed 15 May 2026.